PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34554398-0	2021	Correction to: Efonidipine Exerts Cerebroprotective Effect by Down-regulation of TGF-beta/SMAD-2-Dependent Signaling Pathway in Diabetic Rats.	efonidipine	15-26	SMAD family member 2	Rattus norvegicus	90-96	
21897055-0	2011	Effect of efonidipine on TGF-beta1-induced cardiac fibrosis through Smad2-dependent pathway in rat cardiac fibroblasts.	efonidipine	10-21	SMAD family member 2	Rattus norvegicus	68-73	
21897055-4	2011	TGF-beta1 (5 ng/mL) significantly increased Smad2 phosphorylation and [(3)H]-leucine incorporation, which were attenuated by pretreatment with efonidipine (10 microM).	efonidipine	143-154	SMAD family member 2	Rattus norvegicus	44-49	
21897055-8	2011	These data suggest that efonidipine elicits inhibitory effects on TGF-beta1- and Smad2-dependent protein synthesis through both T-type and L-type calcium channel-blocking actions in cardiac fibroblasts.	efonidipine	24-35	SMAD family member 2	Rattus norvegicus	81-86	
34056691-0	2021	Efonidipine Exerts Cerebroprotective Effect by Down-regulation of TGF-beta/SMAD-2-Dependent Signaling Pathway in Diabetic Rats.	efonidipine	0-11	SMAD family member 2	Rattus norvegicus	75-81	
34056691-10	2021	In conclusion, the study data supports the cerebroprotective role of efonidipine in diabetic animals possibly through TGF-beta/SMAD-2 signaling pathway.	efonidipine	69-80	SMAD family member 2	Rattus norvegicus	127-133